Effect of TXA on Reducing Bruising After Filler Injection
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-89
SponsorUniversity of Wisconsin, Madison
About this trial
The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is:
* Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection?
Participants will receive the study medication along with the standard facial filler injection and complete surveys.
Eligibility criteria
Qualifiers
Age equal to or greater than 18 but less than or equal to 89 years.
Participants interested in facial filler (HA) injection.
English speaking.
Disqualifiers
Minors or under the age of 18
Participant over the age of 89
Pregnant or breast-feeding women
Individuals unable to give consent due to another condition such as impaired decision-making capacity.
Trial design
Treatments tested in this trial
- Hyaluronic Acid (HA)
- Tranexamic Acid (TXA)
- Saline (placebo)
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov